INJE University PharmacoGenomics Research Center

Publications

Projects :
Published Dates :
Select All
Identification of new CYP2C19 variants exhibiting decreased enzyme activity in the metabolism of S-mephenytoin and omeprazole (BMRC, PRCDM)
Drug Metab Dispos. / 37(11):2262-9 [LINK]
2009-International
Ethnic Differences of two Non-synonymous Single Nucleotide Polymorphisms in CDA Gene (BMRC, Japan Fund)
Drug Metab. Pharmacokinet. / 24(6):553?556 [LINK]
2009-International
Isoreserpine promotes beta-catenin degradation via Siah-1 up-regulation in HCT116 colon cancer cells. ()
Biochem Biophys Res Commun (3):444-449 2.750 [LINK]
2009-International
Simultaneous quantification of rosiglitazone and its two major metabolites, N-desmethyl and p-hydroxy rosiglitazone in human plasma by liquid chromatography/tandem mass spectrometry: Application to an pharmacokinetic study (BMRC)
J Chromatogr B Analyt Technol Biomed Life Sci. 877(20-21):1951-6, 2009 Jul 1 [LINK]
2009-International
Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans (BMRC, PRCDM)
Drug Metab Dispos. 37(7):1464-70, 2009 Jul [LINK ]
2009-International
HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies (BMRC)
Biomed Chromatogr. 23(6):568-72, 2009 Jun [LINK]
2009-International
Estimation of the warfarin dose with clinical and pharmacogenetic data (BMRC, PRCDM)
N Engl J Med. 360(8):753-64, 2009 Feb 19 [LINK]
2009-International
Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement (BMRC, PRCDM)
Pharmacogenet Genomics 19(2):103-12, 2009 Feb [LINK]
2008-International
Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of vardenafil and its major metabolite, N-desethylvardenafil, in human plasma: Application to a pharmacokinetic study (RCTC, BMRC)
J Chromatogr B Analyt Technol Biomed Life Sci. 877(1-2):95-100, 2009 Jan [LINK]
Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300 ()
Biochem Biophys Res Commun. 377(4):1304-8, 2008 Dec [LINK]
2008-International